115890-33-0

Upstream product

• 170936-50-2 Toluene-4-sulfonic acid (S)-2-benzyloxy-1-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-ethyl ester 
• 91274-05-4 (2S,3S)-1,2-O-isopropylidene-1,2,3,4-tetrol 
• 117399-58-3 (1S)-2-(benzyloxy)-1-[(4S)-2,2-dimethyl-1,3-dioxolane-4-yl]-ethan-1-ol 
• 92973-40-5 methyl (2R,3S)-3,4-O-isopropylidene-2,3,4-trihydroxybutanoate 
• 1010701-88-8 3-azido-1,2-O-isopropylidene-3-deoxy-D-erythritol 
• 100-39-0 benzyl bromide 

Downstream Products

• 170936-40-0 (6S,7R)-7-Benzyloxymethyl-6-(tert-butyl-diphenyl-silanyloxy)-1,4-dimethyl-[1,4]diazepan-2-one 
• 170936-49-9 (6S,7R)-7-Benzyloxymethyl-6-(tert-butyl-diphenyl-silanyloxy)-4-methyl-[1,4]diazepan-2-one 
• 170936-41-1 Toluene-4-sulfonic acid (2R,3R)-3-azido-4-benzyloxy-2-hydroxy-butyl ester 
• 170936-48-8 [((2S,3R)-3-Azido-4-benzyloxy-2-hydroxy-butyl)-methyl-amino]-acetic acid 
• 170936-38-6 [((2S,3R)-3-Amino-4-benzyloxy-2-hydroxy-butyl)-methyl-amino]-acetic acid 
• 170936-39-7 (6S,7R)-7-Benzyloxymethyl-6-hydroxy-4-methyl-[1,4]diazepan-2-one 
• 170936-42-2 Toluene-4-sulfonic acid (2R,3R)-4-benzyloxy-3-(2-benzyloxycarbonylamino-acetylamino)-2-(tert-butyl-dimethyl-silanyloxy)-butyl ester 
• 170936-46-6 Toluene-4-sulfonic acid (2R,3R)-3-azido-4-benzyloxy-2-(tert-butyl-dimethyl-silanyloxy)-butyl ester 
• 170936-47-7 Toluene-4-sulfonic acid (2R,3R)-3-amino-4-benzyloxy-2-(tert-butyl-dimethyl-silanyloxy)-butyl ester 
• 115890-32-9 (2R,3R)-2-azido-1-(benzyloxy)-3,4-epoxybutane 
• 99884-12-5 (2R,3R)-3-azido-4-(benzyloxy)butane-1,2-diol 

Relevant academic research and scientific papers

Origins of the double asymmetric induction on proline-catalyzed aldol reactions

(Chemical Equation Presented) Computational studies to elucidate the origin of the double asymmetric induction on proline-catalyzed aldol reaction have been performed using HF/6-31G(d) calculations. The computed transition structures explain the experimen

Synthesis of the 1,4-diazepan-2-one moiety of liposidomycins

The two stereoisomers 12 and 16 of 1,4-dimethyl-1,4-diazepan-2-one, a central feature of liposidomycins, have been synthesized starting from L-ascorbic acid and sarcosine.